DarioHealth Corp. Files 8-K on Material Agreements
Ticker: DRIO · Form: 8-K · Filed: May 6, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
DarioHealth filed an 8-K detailing material agreements, financial obligations, and equity sales.
AI Summary
On April 30, 2025, DarioHealth Corp. entered into a material definitive agreement, likely related to financing or operations, as indicated by the filing of an 8-K. The company also reported on the creation of a direct financial obligation and unregistered sales of equity securities. This filing provides updates on the company's financial and contractual activities.
Why It Matters
This 8-K filing signals significant corporate actions by DarioHealth Corp., potentially impacting its financial obligations, equity structure, and future operational capacity.
Risk Assessment
Risk Level: medium — The filing indicates potential financial obligations and equity sales, which can introduce financial and market risks for the company.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- April 30, 2025 (date) — Date of earliest event reported
- May 6, 2025 (date) — Date of report
- LabStyle Innovations Corp. (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by DarioHealth Corp. on April 30, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of direct financial obligation was created by DarioHealth Corp.?
The filing states the creation of a direct financial obligation, but the specific terms and nature of this obligation are not detailed in the provided text.
What were the circumstances surrounding the unregistered sales of equity securities by DarioHealth Corp.?
The filing reports on unregistered sales of equity securities, but the details regarding the number of shares, price, and recipients are not present in the provided text.
When did DarioHealth Corp. change its name from LabStyle Innovations Corp.?
DarioHealth Corp. changed its name from LabStyle Innovations Corp. on November 1, 2011.
What is the primary business of DarioHealth Corp. according to its SIC code?
DarioHealth Corp.'s Standard Industrial Classification (SIC) code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding DarioHealth Corp. (DRIO).